Recent guidelines, based on evidence of detrimental pharmacokinetic interactions between antiepileptic drugs (AEDs) and antiretroviral drugs, provide a new framework for the selection of AED medication for HIV-infected individuals. However, AED use, antiretroviral therapy and HIV infection all have overlapping nonpharmacokinetic outcomes, which the guidelines do not address.
- Bruce J. Brew
- Julia Thompson